Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats. - Li J; Stratton HJ; Lorca SA; Grace PM; Khanna R (Channels (Austin, Tex.), 2022)